v3.26.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net income (loss) $ 3,472,480 $ (2,196,875)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 142,049 419,010
Stock-based compensation 10,019 275,642
Change in fair value of warrant liability (667,343)
Noncash revenue from licensing agreement (3,500,000)
Commitment fee 150,000
Changes in operating assets and liabilities:    
Accounts receivable (42,669) 494,708
Prepaid expenses and other assets (117,883) (257,894)
Deferred revenue 470,000
Accounts payable and other liabilities (1,341,879) (2,398,447)
Net cash used in operating activities (1,575,226) (3,513,856)
Cash flows from investing activities:    
Net cash provided by (used in) investing activities
Cash flows from financing activities:    
Proceeds from issuance of Common Stock 1,654
Proceeds from the issuance and exercise of pre-funded warrants 1,500,000
Issuance costs of pre-funded warrants and Common Stock warrants (389,056)
Issuance costs for Common Stock (22,297)
Debt repayment (259,303) (32,460)
Net cash provided by (used in) financing activities 851,641 (53,103)
Net decrease in cash and cash equivalents (723,585) (3,566,959)
Cash and cash equivalents at the beginning of the period 1,952,464 4,674,572
Cash and cash equivalents at the end of the period 1,228,879 1,107,613
Supplemental disclosure of cash flow information:    
Cash paid for interest 171,404 244,269
Noncash financing and investing activities:    
Equity dividend to investor $ 1,488,472